Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

NICE recommends BMS-Pfizer’s Eliquis to prevent stroke

Joins Xarelto and Pradaxa anticoagulants as potential warfarin replacement

- PMLiVE

UCB says new medicines drive growth in 2012

Also optimistic about its late-stage pipeline

Roche - Basel

Roche promises greater access to clinical trial data

Company critics say measures do not go far enough

Novartis to expand SMS for Life approach across Africa

Will broaden reach of mobile-based medicines management programme 

UK flag

UK researchers able to use patented drugs in trials

Patents Act updated to allow comparator studies without risk of patent infringement

Mary Hines

Dabrafenib: promising results for melanoma

The BREAK-2 phase II trial showed that dabrafenib 150mg twice daily had rapid onset of action, high response rates and prolonged progression-free survival

- PMLiVE

Sir Tom Blundell to remain as chair of UK’s biotech research council

Reappointed to government role to support research

- PMLiVE

How to Master Multichannel Marketing in Pharma

Learn how to optimise your multichannel marketing for increased profitability and improved customer engagement.

Blue Latitude Health

- PMLiVE

Sanofi gets EMA backing for multi-disease vaccine in children

Hexyon-Hexacima 6-in-1 paediatric vaccine recommended for approval in Europe

Growing pains at WebMD

Health information site increases traffic but sees falling revenues in 2012

- PMLiVE

Novartis gives Vasella honorary role as payout row continues

Named honorary chairman chairman at Swiss pharma firm after stepping down as chairman

- PMLiVE

Second approval in US for Bayer-Onyx’ Stivarga

FDA clears drug to treat patients with gastrointestinal stromal tumours

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links